HbA1c at term delivery and adverse pregnancy outcome.

ABSTRACT:

Background

There are no obvious thresholds at which the risk of adverse pregnancy outcomes increases as a result of maternal hyperglycemia. HbA1c level which is representative of average blood glucose levels over the last 2-3 months is not as strongly predictive of adverse outcome compared to blood glucose values of oral glucose tolerance test. Data is sparse on the predictive value of HbA1c at term just prior to delivery on adverse outcome. We sought to evaluate HbA1c taken on admission for delivery at term on adverse outcomes of Cesarean delivery and large (≥ 90^th centile) for gestational age (LGA) infants.

Methods

A prospective cross-sectional study was conducted in a university hospital in Malaysia from December 2017-August 2018. 1000 women at term whose deliv

SUBMITTER: Hong JGS 

PROVIDER: S-EPMC9440566 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature